Past events

Join us at this exceptional event, where senior managers, policymakers, commissioners, patients, frontline staff, and industry leaders unite in an inspiring and collaborative atmosphere

The Advanced Therapies Congress brings together speakers from across the entire value chain of cell and gene therapy development, forward-thinking pharma, biotech and start-up companies, researchers, clinicians, academics, HTAs, payers and regulators.

This course offers a clear and practical introduction to statistical thinking tailored to the needs of Medical Affairs. You will learn the essential principles behind statistical analysis, develop the ability to critically assess the validity and relevance of study findings, and gain techniques to clearly communicate statistical results in a medical context.

The goal of this course is to demystify market access for anyone involved. You will be equipped with clear schematic overviews of the market access systems in Europe’s major markets as a resource for reference in your daily work.

The Festival of Biologics brings together pharma & biotech, academics, research institutes, regulators, patients groups and payers together with their partners across the value chain to bring you from discovery to market.

The AMR Conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and specific challenges faced by the innovation ecosystem in bringing new antimicrobial treatments and diagnostics to the market. The conference is the one-stop shop to catch up with the latest trends in the development of AMR products, by covering scientific, regulatory, financial and policy topics.

World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 300 speakers, 8 tracks and 1500+ attendees from pharma, biotech and Payers/HTAs.

Regulators and payers increasingly elevate the importance of Real World Evidence in submission and reimbursement requirements, and the upcoming EHDS regulation marks a landmark move towards data sharing, while increasingly robust AI transforms big data analysis. The 3rd IMPACCT Real World Evidence Summit Europe is the only industry meeting dedicated to uniting experts in RWE, Evidence Generation, and Medical Affairs.

Meet the leaders and decision-makers who are shaping the future of generics and biosimilars. Be inspired by new experiences, real talk and fresh ideas during a period of intense challenges and exciting promise. Join generic and biosimilar industry professionals at Access! 2026.

Think Locally, Act Globally: The New Norms of Market Access at the Davos of the Access World.

Three days of facts, news, discussions and lots of networking. More than 180 participants in the auditorium and over 40 experts on stage

By attending this 2-day course you will quickly get up the learning curve and know how to apply AI most effectively and efficiently in your pharma marketing role. You will not only have the chance to ask your specific questions to a true AI-Pharma Marketing expert, but also benefit from the unique opportunity to share experiences and engage in in-depth discussions with your international peers.

This course will equip you with the knowledge and tools to engage effectively with the right key opinion leaders at the right time in a product’s lifecycle, ensuring the strategic needs of your products are met, as set out in the Medical/Brand Plan.

Most countries have their own Health Technology Assessment (HTA) body with specific views about which criteria to be used and how the HTA process should be conducted. On top of that, EU-level networks strive for a more efficient use of resources and increased collaboration between all stakeholders involved. In this 1-day course you will learn how companies should optimise processes and criteria in this complex environment.

This course is a must for brand/product managers and related pharma marketers early in their career because they need to quickly acquire the concepts and tools for generating successful brand marketing plans, as well as think and learn to act cross-functionally in today’s volatile, uncertain and complex environment. This course will also benefit more experienced brand managers and franchise leads who want to refresh their skills, as well as managers in medical affairs, market access and commercial functions who must contribute to agile and customer-centric brand planning processes.

The goal of this course is to demystify market access for anyone involved. You will be equipped with clear schematic overviews of the market access systems in Europe’s major markets as a resource for reference in your daily work.

Real World Evidence (RWE) has become an essential addition to Randomised Controlled Trials (RCTs) to further reduce regulatory, payer, physician and patient uncertainty. Unfortunately, many companies struggle implementing it. The key ingredient to success is a cross-functional organisation where managers have widespread knowledge of the fundamentals and a shared vocabulary. In this course you will learn the fundamentals of RWE so that you can contribute effectively when decisions are made and/or when implementing RWE studies.

This 2-day workshop is designed for innovative marketing and sales staff who want to enhance customer-centricity through the selective adoption of digital in their communication with HCPs, patients, caregivers

Attending this course is a crucial investment for leaders and key contributors in a country launch team because it offers comprehensive insights and practical tools to manage successful product launches.

To optimise successful transactions and partnerships, companies need a structured business development and licensing process, and all contributors need to understand the whole process. This course offers a unique opportunity to speed up your learning curve by giving you a comprehensive overview of the licensing process in the context of business development in the pharma-biotech world.